April 2025
Assessment of the performance of a dual-sample oral cholate challenge test: The HepQuant DuO test
| Clinica Chimica Acta | April 2025
Liver health is currently evaluated using nonspecific blood tests, fibrosis surrogates, and invasive procedures, none of which directly measure liver function and physiology. The validated HepQuant SHUNT test quantifies liver function and physiology and is linked to clinical outcomes. Herein we present the reliability of a simplified version, the dual-sample oral cholate challenge (HepQuant DuO) test. read more →
March 2025
Letter to the Editor: Enhancing the Diagnostic Performance of the Oral Cholate Challenge Test: Implications for Avoidance of Potentially Unnecessary Endoscopy
| Alimentary Pharmacology & Therapeutics| March 2025
March 2025
Rencofilstat Treatment Improves Liver Function in MASH With Advanced Fibrosis as Quantified by HepQuant DuO
| Liver International | 01 March 2025
November 2024
Measuring the Risk of Clinical Events (RISK ACE) by Quantifying Liver Function: A Patient-Centric Model
| European Journal of Internal Medicine 2024; 132:160-163 | 29 November 2024
Advances in Noninvasive Measurement of Liver Function and Physiology: The HepQuant DuO Test
| Basic Clin Pharmacol Toxicol 2024 Jan 15. Mar;134(3):385-395
Alterations in Liver Perfusion in Adults with Fontan Circulation as Assessed by Dual Cholate Clearance
| Journal of the American Heart Association | 2025 | March 2025
Cost-Effectiveness of an Oral Cholate Challenge Test for the Management of Patients at Risk for Large Esophageal Varices
| Research Article | published 22 November 2024 PLOS ONE
Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT-V Study.
| Alimentary Pharmacology & Therapeutics, 2024; 61: 75-87
A Validated LC-MS/MS Assay for the Quantitation of Cholate Isotopes in Human Serum
| The Journal of Applied Laboratory Medicine 2024 Aug 16